Not Yet RecruitingNCT07144072
Safety and Tolerability Study of Mesenchymal Stem Cells, HeXell-2020, in Elderly Subjects With Mild to Moderate Frailty Syndrome
PHASE1 · 12 planned enrolment
- Countries listed
- 0
- Registry update
- September 25, 2026
immortal.lifeVerify the exact trial registrations behind a company, intervention, programme or topic count.
Showing 1–1 of 1. Every record below meets all the filters shown above.
PHASE1 · 12 planned enrolment